PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 9069784

Designing a computerized data collection tool for access management.

C Sandmann
View original source ↗Export metadata ↓

Abstract

Collecting data for continuing quality improvement can be a barrier for staff. Data collection can be stressful and time consuming. If not carefully planned it may not provide desired information. Satellite Dialysis Centers recently developed a new data collection tool for vascular access management that was incorporated into our clinical information system. The goal of this project was to collect meaningful accurate information concerning vascular access in a manner that would not increase the dialysis staff work load. This article will outline the measures taken by Satellite Dialysis Centers to automate data collection concerning dialysis access management, including how desired data were identified and strategies for ensuring data entry compliance.

Explore related subjects

Arteriovenous Shunt, SurgicalData CollectionDatabase Management SystemsHumansQuality Assurance, Health CareRenal DialysisJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

C Sandmann. 1996. Designing a computerized data collection tool for access management.. https://pubmed.ncbi.nlm.nih.gov/9069784/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1999

Comparison of venoarterial versus venovenous access in the cerebral circulation of newborns undergoing extracorporeal membrane oxygenation.

This study was designed to compare venoarterial (VA) with venovenous (VV) access in the cerebral circulation of newborn infants during extracorporeal membrane oxygenation (ECMO). Among 14 infants with VA ECMO, 7 had no intracranial complications (group 1), while the others (group 2) developed intracranial hemorrhage (ICH). In contrast, among 19 infants with VV ECMO, only 1 developed ICH. Serial echocardiograms were performed before and after 1, 6, 12, and 24 h and 2 and 3 days of ECMO. The mean cerebral blood flow (CBF) velocities were measured in the anterior cerebral artery (ACA), right and left internal carotid arteries (Rt, Lt-ICA), basilar artery (BA), and right and left middle cerebral arteries (Rt, Lt-MCA). Ejection fraction (EF), cardiac output (CO), and stroke volume (SV) were also measured using standard echography. The velocity levels in the ACA, Rt-MCA, and Lt-MCA in VA ECMO were lower than those in VV ECMO, while those in the Lt-ICA and BA in VA ECMO were higher than those in VV ECMO. The EF, CO, and SV were lower in cases of VA ECMO than in VV ECMO. In cases of VA ECMO, there were no differences between groups 1 and 2 in velocities in the ACA, Rt-ICA, or Lt-ICA. However the velocities in group 2 in the BA, Rt-MCA, and Lt-MCA were lower than those in group 1 before and during ECMO. Similarly, the EF, CO, and SV were lower in group 2 (12.0%-31.0%, 0. 10-0.32 l/min, and 0.66-1.55 ml, respectively) than in group 1 (29. 5%-49.3%, 0.25-0.63 l/min, and 2.15-3.85 ml) during ECMO. However, in the infants on VV ECMO the CBF was either maintained or gradually increased before and during ECMO. Their cardiac parameters were: EF 46.1%-53.0%, CO 0.43-0.52 l/min, and SV 2.72-3.84 ml during ECMO. It is concluded that in VA ECMO CBF velocities, particularly in infants who developed ICH, decreased after the onset of ECMO in association with poor cardiac function, while in VV ECMO they were stable, probably due to normal systemic hemodynamics and cardiac function.

Arteriovenous Shunt, Surgical↗
PubMed1999

A prospective evaluation of PTFE graft patency and surveillance techniques in hemodialysis access.

The purpose of this study was to perform a prospective multicenter evaluation of the patency, complications, and predictive factors of patency for 6-mm expanded polytetrafluoroethylene (ePTFE) grafts used in hemodialysis access. Eighty-six patients were evaluated; the mean age was 55.8 years (range 23-90), 46 patients were female. Patency and complications were assessed at the initial dialysis and 1, 3, 6, 9, and 12 months postoperatively. Kaplan-Meier survival curves were calculated to determine primary and secondary patency, and log-rank analysis was used to determine differences between curves. The Student's t-test was used to compare groups. Primary and secondary patency rates at 1 year were 43% and 64%. Venous line pressures tended to rise over time. Recirculation values and blood flow rates during dialysis showed no correlation to graft patency. These results show that ePTFE provides a suitable secondary choice for vascular access for end-stage renal disease patients in whom an autogenous fistula is not possible. Thrombosis and anastomotic stenosis are common and should be aggressively identified and treated to prolong overall graft survival.

Arteriovenous Shunt, Surgical↗